Risk of adverse cardiovascular outcomes and new diabetes with combination therapy in hypertensive patients with coronary artery disease: the INternational VErapamil SR-Trandolapril STudy (INVEST)

dc.contributor.author	Pelpine, CJ
dc.contributor.author	Mancia, G
dc.contributor.author	Keltai, M
dc.contributor.author	Erdine, S
dc.contributor.author	Hewkin, A
dc.contributor.author	Kupfer, S
dc.date.accessioned	2021-03-06T19:52:26Z
dc.date.available	2021-03-06T19:52:26Z
dc.identifier.citation	Mancia G., Keltai M., Erdine S., Hewkin A., Kupfer S., Pelpine C., "Risk of adverse cardiovascular outcomes and new diabetes with combination therapy in hypertensive patients with coronary artery disease: the INternational VErapamil SR-Trandolapril STudy (INVEST)", ESC Congress 2004, Munich, Almanya, 28 Ağustos - 01 Eylül 2004, cilt.25, ss.423-424
dc.identifier.other	vv_1032021
dc.identifier.other	av_f856cd40-867b-4baa-a967-eed20a95455d
dc.identifier.uri	http://hdl.handle.net/20.500.12627/162679
dc.language.iso	eng
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	Kardiyoloji
dc.subject	Klinik Tıp
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	CARDIAC ve CARDIOVASCULAR SİSTEMLER
dc.title	Risk of adverse cardiovascular outcomes and new diabetes with combination therapy in hypertensive patients with coronary artery disease: the INternational VErapamil SR-Trandolapril STudy (INVEST)
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	25
dc.contributor.firstauthorID	130189

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.